The role of nail-videocapillaroscopy in early diagnosis of scleroderma

Autoimmunity Reviews

Volumn 12, Issue 8, 2013, Pages 821-825

  Rossi, Daniela ^a   Russo, Alessandra ^a   Manna, Erika ^a   Binello, Giovanni ^a   Baldovino, Simone ^a   Sciascia, Savino ^a   Roccatello, Dario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Early diagnosis; Microangiopathy; Nailfold videocapillaroscopy; Systemic sclerosis

Indexed keywords

CAPILLAROSCOPY; CLINICAL EVALUATION; CLINICAL RESEARCH; CRYOGLOBULINEMIA; DISEASE COURSE; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; MICROANGIOPATHY; NAILFOLD VIDEOCAPILLAROSCOPY; PREDICTIVE VALUE; RAYNAUD PHENOMENON; REVIEW; SCLERODERMA; SEX DIFFERENCE; SYSTEMIC SCLEROSIS;

CONNECTIVE TISSUE DISEASES; EARLY DIAGNOSIS; HUMANS; MICROSCOPIC ANGIOSCOPY; NAILS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 84878526859     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.11.006     Document Type: Review

References (57)

1. Kahaleh M.B. Raynaud's phenomenon and vascular disease in scleroderma. Curr Opin Rheumatol Nov 1994, 6(6):621-627.
2. Maricq H.R., Weinrich M.C., Keil J.E., Smith E.A., Harper F.E., Nussbaum A.I., et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989, 32:998-1006.
3. Cipriani P., Marrelli A., Liakouli V., Di Benedetto P., Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev Aug 2011, 10(10):641-646.
4. Defendenti C., Atzeni F., Spina M.F., Grosso S., Cereda A., Guercilena G., et al. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. Autoimmun Rev Jan 2011, 10(3):150-154.
5. Lambova Sevdalina Nikolova, Müller-Ladner Ulf The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 2009, 29:1263-1271.
6. Bergman R., Sharony L., Schapira D., Nahir M.A., Balbir-Gurman A. The handheld dermatoscope as a nail-foiled capillaroscopic instrument. Arch Dermatol 2003, 139:1027-1030.
7. Formosa P. Nailfold capillaroscopy techniques. J Rheumatol 2009, 23:37-429.
8. Maricq H.R., LeRoy E.C., D'Angelo W.A., Medsger T.A., Rodnan G.P., Sharp G.C., et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980, 23(2):183-189.
9. Cutolo M., Grassi W., Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003, 48(11):3023-3030.
10. Cutolo M., Pizzorni C., Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol 2005, 19(3):437-452.
11. Cutolo M., Sulli A., Secchi M.E., Olivieri M., Pizzorni C. The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases. Best Pract Res Clin Rheumatol 2007, 21(6):1093-1108.
12. Kabasakal Y., Elvins D.M., Ring E.F., McHugh N.J. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996, 55:507-512.
13. Lee P., Leung F.Y., Alderdice C., Armstrong S.K. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 1983, 10(6):930-938.
14. LeVord F., Edwards J.C.W. Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 1986, 45:741-749.
15. Maricq H.R., Harper F.E., Khan M.M., Tan E.M., LeRoy E.C. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983, 1(3):195-205.
16. Maricq H.R. Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res 1986, 32(2):271-276.
17. Cutolo M., Pizzorni C., Meroni M., Zampogna G., Ferrone C., Alessandri E., et al. The role of nailfold videocapillaroscopy in Raynaud's phenomenon monitoring and early diagnosis of systemic sclerosis. Reumatismo 2010, 62(4):237-247.
18. Gitzeimann G. Predictive value of nailfold capillaroscopy in patients with Raynaud phenomenon. Clin Rheumatol 2006, 25:153-158.
19. Cutolo M., Sulli A., Secchi M.E., Paolino S., Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic disease. A future tool for the analysis of microvascular heart involvement?. Rheumatology 2006, 45:iv43-iv46.
20. Cutolo M., Pizzorni C., Sulli A. Nailfold video-capillaroscopy in systemic sclerosis. Rheumatology 2004, 63:457-462.
21. Luggen M., Belhorn L., Evans T., Fitzgerald O., Spencer-Green G. The evolution of Raynaud's phenomenon: a longterm prospective study. J Rheumatol 1995, 22:2226-2232.
22. Herrick A.L. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol Aug 2012, 8(8):469-479.
23. Fitzgerald O., Hess E.V., O'Connor G.T., Spencer-Green G. Prospective study of the evolution of Raynaud's phenomenon. Am J Med 1988, 84:718-726.
24. Ingegnoli F., Boracchi P., Gualtierotti R., Lubatti C. Prognostic model based on nailfold capillaroscopy for identifyind Raynaud's phenomenon patients at hig risk for the development of a sclerodrerma spectrum disorder PRINCE (prognostic index for nailfold capillaroscopic examination). Arthritis Rheum July 2008, 58(7):2174-2182.
25. Ho M., Belch J.J.F. Raynaud's phenomenon: state of the art. Scand J Rheumatol 1998, 27:319-322.
26. Steven A.O. Raynaud's phenomenon. Secrets of rheumatology 2001, 614-619. Binom, Moscow. J.B. Sterling (Ed.).
27. Szekanecz E., Szamosi S., Horváth A., Németh A., Juhász B., Szántó J., et al. Malignancies associated with systemic sclerosis. Autoimmun Rev Oct 2012, 11(12):852-855.
28. Racanelli V., Prete M., Minoia C., Favoino E., Perosa F. Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev May 2008, 7(5):352-358.
29. Galluccio F., Matucci-Cerinic M. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis. Autoimmun Rev Mar 2011, 10(5):241-243.
30. Chung L., Fiorentino D. Digital ulcers in patients with systemic sclerosis. Autoimmun Rev Feb 2006, 5(2):125-128.
31. Hirschl M., Hirschl K., Lenz M., Katzenschlager R., Hutter H.P., Kundi M. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance. Arthritis Rheum 2006, 54(6):1974-1981.
32. Cutolo M., Pizzorni C., Sulli A. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al. Arthritis Rheum 2007, 56(6):2102-2103.
33. Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998, 158:595-600.
34. Hudson M., Fritzler M.J., Baron M. Systemic sclerosis: establishing diagnostic criteria. Medicine (Baltimore) May 2010, 89(3):159-165.
35. Kallenberg C.G. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am 1990, 16:11-30.
36. Maricq H.R., Carpentier P.H., Weinrich M.C., Keil J.E., Palesch Y., Biro C., et al. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. J Rheumatol 1997, 24:879-889.
37. Chighizola C., Shoenfeld Y., Meroni P.L. Systemic sclerosis. Introduction. Autoimmun Rev Mar 2011, 10(5):239-240.
38. Carpentier P.H., Maricq H.R. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 1990, 16:75-91.
39. Cutolo M., Sulli A., Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 2010, 6:578-587.
40. Colaci M., Giuggioli D., Sebastiani M., Manfredi A., Vacchi C., Spagnolo P., et al. Lung cancer in scleroderma: results from an Italian Rheumatologic Centre and review of the literature. Autoimmun Rev Jun 25 2012.
41. Cutolo M., Pizzorni C., Tuccio M., Burroni A., Craviotto C., Basso M., et al. Nailfold capillaroscopy patters and serum autoantibodies in systemic sclerosis. Rheumatology 2004, 43:719-726.
42. Sulli A., Secchi M.E., Pizzorni C., Cutolo M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis Jun 2008, 67(6):885-887.
43. Cutolo M., Pizzorni C., Secchi M.E., Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol 2008, 22(6):1093-1108.
44. Sulli A., Secchi M.E., Pizzorni C., Cutolo M. Scoring the nailfold microvascular changed during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008, 67:885-887.
45. Sulli A., Pizzorni C., Smith V., Zampogna G., Ravera F., Cutolo M. Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum 2012, 64:821-825.
46. Priollet P., Vayssairat M., Housset E. How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases. Am J Med 1987, 83(3):494-498.
47. Riccieri V., Spadaro A., Ceccarelli F., Scrivo R., Germano V., Valesini G. Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus 2005, 14(7):521-525.
48. Pallis M., Hopkinson N., Powell R. Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease. Rheumatology 1991, 18(10):1532-1536.
49. Granier F., Vayssairat M., Priollet P., Housset E. Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum 1986, 29(2):189-195.
50. Rossi D., Mansouri M., Baldovino S., Naretto C., Alpa M., Sena L.M., et al. Nail fold videocapillaroscopy in mixed cryoglobulinemia. Nephrol Dial Transplant 2004, 19:2245-2249.
51. Guiducci S., Giacomelli R., Cerinic M.M. Vascular complications of scleroderma. Autoimmun Rev Sep 2007, 6(8):520-523.
52. Bussone G., Mouthon L. Interstitial lung disease in systemic sclerosis. Autoimmun Rev Mar 2011, 10(5):248-255.
53. Almeida I., Faria R., Vita P., Vasconcelos C. Systemic sclerosis refractory disease: from the skin to the heart. Autoimmun Rev Sep 2011, 10(11):693-701.
54. Tiev K.P., Cabane J. Digestive tract involvement in systemic sclerosis. Autoimmun Rev Nov 2011, 11(1):68-73. [Epub 2010 Jun 22].
55. Lambova S., Müller-Ladner U. Pulmonary arterial hypertension in systemic sclerosis. Autoimmun Rev Sep 2010, 9(11):761-770.
56. Dieudé P., Boileau C., Allanore Y. Immunogenetics of systemic sclerosis. Autoimmun Rev Mar 2011, 10(5):282-290.
57. Grassi W., Del Medico P., Izzo F., Cervini C. Microvascular Involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum June 2001, 30(6):397-402.